Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: South Korea Clear all

190 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20051
20066
20075
200817
200914
201024
20118
201211
201311
20148
20159
20165
20177
20185
20196
20206
20215
202210
20237
20243
20257
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149
Recruiting16
Terminated14
Unknown status6
Active, not recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca29
Eli Lilly and Company22
Novo Nordisk A/S20
Sanofi15
Boehringer Ingelheim13
Daewoong Pharmaceutical Co. LTD.8
GlaxoSmithKline8
Hoffmann-La Roche8
Handok Inc.6
Janssen Research & Development, LLC6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2190
Diabetes Mellitus36
Obesity10
Overweight9
Hyperglycemia7
Cardiovascular Diseases6
Dyslipidemias5
Glucose Metabolism Disorders4
Metabolic Diseases4
Renal Insufficiency, Chronic4

Trials

Showing 1 to 25 of 190. Each trial links to its page on Pharma Observatory.

90 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.